Antibiotic resistance, often considered a concern limited to hospitals, is increasingly recognized as a widespread environmental issue. Recent research highlights that environments such as rivers, soils, wastewater, and even air can serve as reservoirs for antibiotic resistance genes, which may eventually impact human and animal health.
A new review published in BioContamination on January 23, 2026, by researchers from Tsinghua University and collaborating institutions examines the role of advanced DNA sequencing technologies in monitoring environmental antibiotic resistance. The study brings together recent advances in metagenomic tools that help detect antibiotic resistance genes, trace their movement through mobile genetic elements, and assess the associated risks.
"Antibiotic resistance is not confined to clinics or farms," said Bing Li of Tsinghua University, the corresponding author of the study. "Environmental systems connect human, animal, and ecological health, and metagenomics gives us a powerful lens to see how resistance genes circulate across these boundaries."
Traditional laboratory methods focused on culturing bacteria capture only a small portion of microbes found in environmental samples. In contrast, metagenomic sequencing analyzes all DNA extracted from samples directly. This approach allows scientists to identify resistance genes present in both culturable and unculturable microorganisms.
The review notes that second generation sequencing technologies such as Illumina platforms have become central to studies of environmental resistomes because of their accuracy and affordability. These tools facilitate large-scale surveys tracking the diversity of resistance genes across various ecosystems globally. However, short read lengths can make it difficult to determine exactly where these genes are located or which organisms harbor them.
To overcome this limitation, third generation long read sequencing platforms like Oxford Nanopore and PacBio are increasingly being used. These technologies provide longer DNA sequences that clarify whether resistance genes are part of chromosomes or mobile genetic elements such as plasmids—an important distinction since mobile genes are more likely to spread between bacteria and increase public health risks.
"Knowing that a resistance gene exists is only the first step," Li explained. "Understanding its mobility and host context is what allows us to evaluate its real world threat."
The authors also discuss new approaches for more accurate quantification of antibiotic resistance genes. While traditional metagenomics offers relative abundance data, newer strategies integrate sequencing with internal standards or quantitative PCR methods to estimate absolute gene copy numbers. This progress enables comparisons of resistance levels across different environments over time.
Another focus is linking detected resistance genes back to their microbial hosts using methods like genome binning, proximity ligation techniques, and single cell analysis. Such efforts improve risk assessment by clarifying which bacteria carry particular resistance traits.
The review suggests integrating gene detection with host identification and quantitative analysis for a comprehensive evaluation framework supporting the One Health concept—the idea that human health cannot be separated from environmental or animal health.
"Environmental surveillance should be considered a frontline defense against antibiotic resistance," Li said. "With continued improvements in metagenomic methods, we are moving closer to early warning systems that can inform risk management and policy decisions before resistance reaches the clinic."
The study concludes that addressing antibiotic resistance will require not just developing new medications but also enhancing surveillance tools to better track how resistant traits move through environmental systems.
